Andrea S. Blevins Primeau, PhD, MBA, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Fri, 08 Mar 2024 14:58:26 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Andrea S. Blevins Primeau, PhD, MBA, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 Despite More Vaccinations, Cancer Survivors More Likely to Have Long COVID https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/cancer-survivors-long-covid/ Fri, 08 Mar 2024 14:15:00 +0000 https://www.oncologynurseadvisor.com/?p=117007 Simple Hysterectomy Noninferior to Radical Hysterectomy in Low-Risk Cervical Cancer https://www.oncologynurseadvisor.com/home/cancer-types/cervical-cancer/simple-radical-hysterectomy-low-risk-cervical-cancer/ Fri, 08 Mar 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=117042 How Traveling Oncologists Can Benefit Rural Cancer Patients https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/traveling-oncologists-rural-cancer-patients/ Thu, 07 Mar 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=117043 Historical Redlining, Contemporary Mortgage Discrimination Linked to Breast Cancer Outcomes https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/historical-redlining-contemporary-mortgage-discrimination-breast-cancer/ Fri, 01 Mar 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116941 Perioperative Tislelizumab Improves Outcomes in NSCLC https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/perioperative-tislelizumab-improves-outcomes-in-nsclc/ Wed, 28 Feb 2024 13:45:00 +0000 https://www.oncologynurseadvisor.com/?p=116834 Durable Responses Achieved With Venetoclax Plus Obinutuzumab in CLL/SLL https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/cll-sll-leukemia-durable-response-venetoclax-obinutuzumab-treatment-risk/ Tue, 27 Feb 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116931 Conventional and Hypofractionated Radiotherapy Produce Similar Outcomes in Breast Cancer https://www.oncologynurseadvisor.com/home/general-medicine/conventional-hypofractionated-radiotherapy-similar-outcomes-breast-cancer/ Mon, 26 Feb 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116802 Pegargiminase Confers Survival Benefit in Nonepithelioid Pleural Mesothelioma https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/pegargiminase-survival-benefit-nonepithelioid-pleural-mesothelioma/ Fri, 23 Feb 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116803 Alpelisib May Cause Diabetic Ketoacidosis in Patients With Breast Cancer https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/alpelisib-diabetic-ketoacidosis/ Fri, 23 Feb 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116702 Survey Reveals Inconsistent Use of Metastasis-Directed Therapy in Colorectal Cancer https://www.oncologynurseadvisor.com/home/cancer-types/colorectal-cancer/metastasis-directed-therapy-colorectal-cancer-survey/ Wed, 21 Feb 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116668